Predictions
China Water Affairs Group
Start price
Target price
Perf. (%)
€0.50
29.12.23
29.12.23
-
29.12.24
29.12.24
21.41%
02.07.24
02.07.24
Hang Lung Properties Ltd
Start price
Target price
Perf. (%)
€1.42
30.05.23
30.05.23
-
30.05.24
30.05.24
-41.20%
31.05.24
31.05.24
Orient Overseas International Ltd.
Start price
Target price
Perf. (%)
€12.39
25.05.23
25.05.23
-
25.05.24
25.05.24
30.26%
26.05.24
26.05.24
Geely Automobile Holdings
Start price
Target price
Perf. (%)
€2.75
18.10.21
18.10.21
-
31.12.25
31.12.25
-63.76%
11.03.24
11.03.24
Could be worthwhile Investment >10% per year
Hutchison China MediTech Ltd ADR
Start price
Target price
Perf. (%)
€16.10
02.03.23
02.03.23
-
02.03.24
02.03.24
-13.04%
03.03.24
03.03.24
Melco Crown Entertain. ADR
Start price
Target price
Perf. (%)
€12.30
19.01.23
19.01.23
-
19.01.24
19.01.24
-44.31%
20.01.24
20.01.24
Hutchison China MediTech Ltd ADR
Start price
Target price
Perf. (%)
€15.50
19.01.23
19.01.23
-
19.01.24
19.01.24
-21.29%
20.01.24
20.01.24
Melco International Subdiv.
Start price
Target price
Perf. (%)
€1.18
19.01.23
19.01.23
-
19.01.24
19.01.24
-53.81%
20.01.24
20.01.24
Geely Automobile Holdings
Start price
Target price
Perf. (%)
€1.48
05.12.22
05.12.22
-
05.12.23
05.12.23
-34.45%
06.12.23
06.12.23
K. Wah International Holdings Ltd.
Start price
Target price
Perf. (%)
€0.27
05.09.23
05.09.23
-
05.09.24
05.09.24
-12.41%
24.10.23
24.10.23
Citic Resources Holdings
Start price
Target price
Perf. (%)
€0.052
03.02.23
03.02.23
-
03.02.24
03.02.24
-35.58%
24.10.23
24.10.23
Shougang Fushan Res. Gr.
Start price
Target price
Perf. (%)
€0.34
01.02.23
01.02.23
-
01.02.24
01.02.24
-14.71%
24.10.23
24.10.23
Alibaba Health Information Technology Ltd
Start price
Target price
Perf. (%)
€0.45
03.10.22
03.10.22
€0.69
03.10.23
03.10.23
27.04%
04.10.23
04.10.23
Revenue growth >5% per year expected
Low dividend yield expected
Risky balance sheet
ROE lower than 10% per year
China Mobile Ltd
Start price
Target price
Perf. (%)
€7.48
14.06.23
14.06.23
€6.00
14.06.24
14.06.24
3.88%
28.08.23
28.08.23
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation